Get the Stockscreener App
81.92
5.74%
-4.99
After Hours:
82.50
0.58
+0.71%
Lantheus Holdings Inc Stock (LNTH) Latest News
William Blair Issues Positive Estimate for Lantheus Earnings - Defense World
Lantheus Holdings validates Fair Value model with 59% return since January 2024 - Investing.com India
Trend Tracker for (LNTH) - Stock Traders Daily
Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting - The Bakersfield Californian
Revolutionary Prostate Cancer Detection Breakthrough: Lantheus PYLARIFY Shows Success in Low PSA Patients - StockTitan
Blue Trust Inc. Boosts Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio - MSN
Lantheus Holdings, Inc. (LNTH): Among the Best Low Risk High Growth Stocks To Invest In Now - Insider Monkey
Lantheus goes Evergreen in a $250m upfront deal - BioProcess Insider
12 Best Low Risk High Growth Stocks to Invest In - Insider Monkey
KBC Group NV Has $264,000 Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Janney Montgomery Scott LLC Acquires 5,753 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Janney Montgomery Scott LLC Grows Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Position Increased by Swedbank AB - MarketBeat
SkyOak Wealth LLC Buys 5,000 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Lantheus (NASDAQ:LNTH) Releases FY 2024 Earnings Guidance - MarketBeat
LNTHLantheus Holdings, Inc Latest Stock News & Market Updates - StockTitan
Lantheus Appoints Dr. Morrow to Board of Directors - TipRanks
Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - MSN
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., to Board - citybiz
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member - The Manila Times
Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline - StockTitan
Lantheus Holdings, Inc. Enters Agreement to Acquire Evergreen TheragnosticsOn January 27, 2025, Lantheus Holdings, Inc. (NASDAQ: LNTH) announced that its subsidiary, Lantheus Medical Imaging, Inc., has entered into a definitive Agreement and Plan of - Defense World
LNTH: Evergreen Acquisition Promotes Future Innovation - Research Tree
Lantheus expands in neuro and oncology with LMI and Evergreen acquisitions - Medical Device Network
Lantheus to acquire Evergreen Theragnostics for up to $1 billion - DOTmed
Lantheus (LNTH) Stock Declines Amid Acquisition Announcement - GuruFocus.com
Lantheus Holdings Inc. Announces Strategic Acquisition of Evergr - GuruFocus.com
Lantheus to Acquire Evergreen Theragnostics for $250 Million - MSN
Items Tagged with 'Life Molecular Imaging Ltd.' - BioWorld Online
Lantheus lights up market with $1.025B Evergreen buy - BioWorld Online
Lantheus to Acquire Evergreen Theragnostics to Expand Radiopharmaceutical Capabilities - HIT Consultant
Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront - MM+M Online
Lantheus to acquire Evergreen Theragnostics - MSN
Lantheus to Acquire Evergreen Theragnostics in $1B Deal - USA Herald
Lantheus (NASDAQ:LNTH) Trading Down 5.5%Should You Sell? - MarketBeat
4 Firms Look To Build $1B Sale Of Evergreen Theragnostics - Law360
Lantheus is on a buying spree. Its latest deal is worth up to $1B - The Business Journals
Lantheus lights up market with up to $1B Evergreen buy - BioWorld Online
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio - Benzinga
Lantheus Holdings to Acquire Evergreen Theragnostics - Contract Pharma
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment - GuruFocus.com
Lantheus Holdings to Acquire Evergreen Theragnostics in All-Cash Transaction -January 28, 2025 at 06:52 am EST - Marketscreener.com
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PR Newswire
Lantheus to Acquire Evergreen Theragnostics for Upfront - GlobeNewswire
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive ... - The Bakersfield Californian
Major Radiopharmaceutical Deal: Lantheus's $1B Game-Changing Move Into Cancer Treatment Manufacturing - StockTitan
Goldman Sachs Initiates Coverage of Lantheus Holdings (LNTH) with Buy Recommendation - MSN
AlphaMark Advisors LLC Reduces Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Park Avenue Securities LLC Acquires 513 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Where are the Opportunities in (LNTH) - Stock Traders Daily
Lantheus Holdings (NASDAQ:LNTH) Seems To Use Debt Rather Sparingly - Simply Wall St
0.61%
2.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):